CORDIS · UTILE
The EU-HEALTH INNOVATION MARKETPLACE, the valorization platform for (FP7 Health and H2020 SC1) research results
- Code
UTILE- Programme
- H2020
- Call
SC1-HCO-01-2016- Status
- CLOSED
- Period
- 2017-01-01 – 2019-12-31
Official data · CORDIS · synced 2026-10-17 10:16 · official record
Participants
| Organisations | Role | Country | Grant |
|---|---|---|---|
| PNO Life Sciences & Health B.V. | coordinator | NL | 87 230 € |
| TECH TOUR EUROPE SA | participant | BE | 315 281 € |
| TECH TRANSFER SUMMIT LIMITED | participant | UK | 251 256 € |
| LIFEARC | participant | UK | 228 375 € |
| ASCENION GmbH | participant | DE | 220 266 € |
| PNO CONSULTANTS BV | participant | NL | 186 895 € |
| PNO INNOVATION SRL | participant | IT | 182 750 € |
| KAROLINSKA INSTITUTET INNOVATIONS AB | participant | SE | 175 846 € |
| PNO DIGITAL SRL | participant | IT | 138 375 € |
| VESTLANDETS INNOVASJONSSELSKAP AS | participant | NO | 137 286 € |
| ASSOCIATION OF EUROPEAN SCIENCE & TECHNOLOGY TRANSFER PROFESSIONALS | participant | NL | 39 625 € |
| EUROPROJECT OOD | participant | BG | 36 438 € |
| TECH TOUR GLOBAL EOOD | third party | BG | 0 € |
Description
A recent evaluation of FP7 projects executed by the EC, showed that an estimated 80% of funded Health projects lacks valorisation. The “UTILE” proposal presents the EU-Health Innovation Marketplace, an online tool to better valorise the FP7 Health and Horizon2020 SC1 project results. This marketplace will actively bring together Innovation Providers (i.e. technology push) and the Innovation Developers (i.e. market pull). Moreover, in order to bring technology push and market pull successfully together, all 1200 FP7 Health and Horizon2020 SC1 projects will not only be analysed and defragmented by five high quality TTO’s (including NIH) in a LEAN process. It will also be valued by an elaborate Market & Stakeholder Advisory Committee, existing of Business Developers of 20-35 important pharmaceutical, medtech, biotech companies and Venture Capitalists. Thus here, valorisation of Health results will not be enhanced by just pushing harder, but by defragmenting and presenting these results in a way that the market will better recognize the added value. In addition to the presentation of well valued selected results on the online UTILE Marketplace, technology push and market pull will be actively brought together by a series of offline activities such as specific workshops and roundtables at international and conferences, brokerage events and technology valorisation courses and trainings. Special attention will be given to the participation of SME’s and involvement of Low Performing Countries. UTILE will deliver a self-sustainable platform of functionalities and activities will also enable the valorisation of future Horizon2020 SC1 projects as well as the many more health-related EC-funded health projects (e.g. in the Marie (Skłodowska) Curie actions). The UTILE Marketplace therefore will continue well after the current grant period.
Official data · CORDIS · synced 2026-10-17 10:16 · official record · Licence: © European Union, CC BY 4.0 (Commission reuse policy).